Impact of AdipoR1 expression on breast cancer development

Gynecologic Oncology

Volumn 117, Issue 1, 2010, Pages 134-138

  Pfeiler, Georg ^a   Hudelist, Gernot ^a,b   Wülfing, Pia ^c   Mattsson, Bjoern ^c   Königsberg, Robert ^d   Kubista, Ernst ^a   Singer, Christian F ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b Villach General Hospital   (Austria)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^d LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

Adiponectin; AdipoR1; Breast cancer; DCIS; Immunohistochemistry

Indexed keywords

ADIPONECTIN RECEPTOR 1; PARAFFIN;

ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; BREAST CARCINOGENESIS; CANCER INVASION; CANCER SIZE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE MICROARRAY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; MIDDLE AGED; NEOPLASM INVASIVENESS; RECEPTORS, ADIPONECTIN;

EID: 77949340535     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.12.018     Document Type: Article

References (27)

1. Kadowaki T., Yamauchi T., Kubota N., Hara K., Ueki K., and Tobe K.J. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. Clin. Invest. 116 (2006) 1784-1792
2. Funahashi T., Nakamura T., Shimomura I., et al. Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. Intern. Med. 38 (1999) 202-206
3. Berg A.H., Combs T.P., Du X., Brownlee M., and Scherer P.E. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat. Med. 7 (2001) 947-953
4. Yamauchi T., Kamon J., Waki H., et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7 (2001) 941-946
5. Yamauchi T., Kamon J., Ito Y., et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423 (2003) 762-769
6. Cust A.E., Kaaks R., Friedenreich C., et al. Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women. J Clin Endocrinol Metab 92 (2007) 255-263
7. Michalakis K., Williams C.J., Mitsiades N., et al. Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: a case control study. Cancer Epidemiol. Biomarkers Prev. 16 (2007) 308-313
8. Wei E.K., Giovannucci E., Fuchs C.S., Willett W.C., and Mantzoros C.S. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J. Natl. Cancer Inst. 97 (2005) 1688-1694
9. Mantzoros C., Petridou E., Dessypris N., et al. Adiponectin and breast cancer risk. J. Clin. Endocrinol. Metab. 89 (2004) 1102-1107
10. Arditi J.D., Venihaki M., Karalis K.P., and Chrousos G.P. Antiproliferative effect of adiponectin on MCF7 breast cancer cells: a potential hormonal link between obesity and cancer. Horm. Metab. Res. 39 (2007) 9-13
11. Dieudonne M.N., Bussiere M., Dos Santos E., Leneveu M.C., Giudicelli Y., and Pecquery R. Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. Biochem. Biophys. Res. Commun. 345 (2006) 271-279
12. Luo Z., Saha A.K., Xiang X., and Ruderman N.B. AMPK, the metabolic syndrome and cancer. Trends Pharmacol. Sci. 26 (2005) 69-76
13. Körner A., Pazaitou-Panayiotou K., Kelesidis T., et al. Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies. J Clin Endocrinol Metab 92 (2007) 1041-1048
14. Wang Y., Lam J.B., Lam K.S., et al. Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice. Cancer Res. 66 (2006) 11462-11470
15. Yamauchi T., Nio Y., Maki T., et al. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat. Med. 13 (2007) 332-339
16. Takahata C., Miyoshi Y., Irahara N., Taguchi T., Tamaki Y., and Noguchi S. Demonstration of adiponectin receptors 1 and 2 mRNA expression in human breast cancer cells. Cancer Lett. 250 (2007) 229-236
17. Hudelist G., Wuelfing P., Czerwenka K., et al. Beta-hCG/LH receptor (b-HCG/LH-R) expression is increased in invasive versus preinvasive breast cancer: implications for breast carcinogenesis?. J. Cancer Res. Clin. Oncol. 135 (2009) 191-195
18. Miyoshi Y., Funahashi T., Kihara S., et al. Association of serum adiponectin levels with breast cancer risk. Clin. Cancer Res. 9 (2003) 5699-5704
19. Chen D.C., Chung Y.F., Yeh Y.T., et al. Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Lett. 237 (2006) 109-114
20. Kang J.H., Lee Y.Y., Yu B.Y., et al. Adiponectin induces growth arrest and apoptosis of MDA-MB-231 breast cancer cell. Arch. Pharm. Res. 28 (2005) 1263-1269
21. Treeck O., Lattrich C., Juhasz-Boess I., Buchholz S., Pfeiler G., and Ortmann O. Adiponectin differentially affects gene expression in human mammary epithelial and breast cancer cells. Br. J. Cancer 99 (2008) 1246-1250
22. Motoshima H., Goldstein B.J., Igata M., and Araki E. AMPK and cell proliferation-AMPK as a therapeutic target for atherosclerosis and cancer. J. Physiol. 574 (2006) 63-71
23. Jardé T., Caldefie-Chézet F., Goncalves-Mendes N., et al. Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies. Endocr. Relat. Cancer 16 (2009) 1197-1210
24. Grossmann M.E., Nkhata K.J., Mizuno N.K., Ray A., and Cleary M.P. Effects of adiponectin on breast cancer cell growth and signaling. Br. J. Cancer 98 (2008) 370-379
25. Pfeiler G.H., Buechler C., Neumeier M., et al. Adiponectin effects on human breast cancer cells are dependent on 17-beta estradiol. Oncol. Rep. 19 (2008) 787-793
26. Nakayama S., Miyoshi Y., Ishihara H., and Noguchi S. Growth-inhibitory effect of adiponectin via adiponectin receptor 1 on human breast cancer cells through inhibition of S-phase entry without inducing apoptosis. Breast Cancer Res. Treat 112 (2008) 405-410
27. Tworoger S.S., Eliassen A.H., Kelesidis T., et al. Plasma adiponectin concentrations and risk of incident breast cancer. J. Clin. Endocrinol. Metab. 92 (2007) 1510-1516